Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Erika L. Crowley"'
Autor:
Erika L. Crowley, Melinda J. Gooderham
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 23 (2023)
Psoriasis is a common chronic immune-mediated disease with many comorbidities and impacts on quality of life. Among the treatments for psoriasis, phosphodiesterase-4 (PDE4) inhibitors are emerging with expanding options. PDE4 inhibitors play a pivota
Externí odkaz:
https://doaj.org/article/1e0e3b8c76b145bf8f47f9b2bb9ad716
Autor:
Keira A Fieldhouse, Samantha Ukaibe, Erika L Crowley, Reena Khanna, Ashley O’Toole, Melinda J Gooderham
Publikováno v:
Drugs in Context, Vol 9, Pp 1-9 (2020)
Background: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established i
Externí odkaz:
https://doaj.org/article/03a0a95c1145443f9bea40172b374cfc
Autor:
Erika L Crowley, Khalad Maliyar, Fabian Rodriguez-Bolanos, Ashley O’Toole, Melinda J Gooderham
Publikováno v:
SAGE Open Medical Case Reports, Vol 7 (2019)
Acrodermatitis continua of Hallopeau is a chronic, inflammatory, and relapsing condition that presents as pustules of the fingers and toes, often with nail involvement. This condition is infrequently reported, difficult to treat, and often misdiagnos
Externí odkaz:
https://doaj.org/article/9ca6eb2dbe5b446391b96f529a407bff
Publikováno v:
SAGE Open Medical Case Reports, Vol 6 (2018)
Introduction: Hidradenitis suppurativa and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome are chronic, debilitating diseases involving apocrine gland-bearing skin inflammation and bone inflammation, respectively. Although both often pre
Externí odkaz:
https://doaj.org/article/51f3746778624aaf96a1554e1e381ce1
Publikováno v:
Expert Review of Clinical Immunology. 16:955-962
Janus kinase (JAK) inhibitors are emerging treatments in dermatology. Also known as JAKinibs, these agents target JAK-signal transducers and activators of transcription (JAK-STAT) pathway for intracellular signaling. Among the various immune-mediated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01199f143973136fe4a7fe57e9ff43a1
https://doi.org/10.1080/1744666x.2021.1828068
https://doi.org/10.1080/1744666x.2021.1828068
Publikováno v:
Expert Opinion on Investigational Drugs. 29:911-917
Atopic dermatitis (AD) is a common and debilitating dermatosis that often impacts the physical and psychological quality of life in children and adults. A limited number of treatment options are available for AD, and often these treatments result in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1217e29fde7f076b66842c870754e5
https://doi.org/10.1080/13543784.2020.1804854
https://doi.org/10.1080/13543784.2020.1804854
Publikováno v:
Journal of Cutaneous Medicine and Surgery. 24:619-624
Deoxycholic acid (BELKYRATM, Allergan, Markham, ON, Canada) is a minimally invasive injectable treatment approved by Health Canada for the nonsurgical reduction of submental fullness. Multiple phase III clinical trials have proven the efficacy and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17e596a50fb5a9b73645614413bc399
https://doi.org/10.1177/1203475420943270
https://doi.org/10.1177/1203475420943270
Autor:
Melinda Gooderham, Keira A Fieldhouse, Samantha Ukaibe, Reena Khanna, Ashley O’Toole, Erika L Crowley
Publikováno v:
Drugs in Context, Vol 9, Pp 1-9 (2020)
Drugs in Context
Drugs in Context
Background: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be608524c2595abf97276e2eb92aaac
https://www.drugsincontext.com/inflammatory-bowel-disease-in-patients-with-psoriasis-treated-with-interleukin-17-inhibitors
https://www.drugsincontext.com/inflammatory-bowel-disease-in-patients-with-psoriasis-treated-with-interleukin-17-inhibitors
Publikováno v:
Journal of Cutaneous Medicine and Surgery. 23:289-297
Alopecia areata (AA) is a chronic, immune-mediated disorder that targets hair follicle epithelium, thereby restricting hair growth in localized patches. Although several therapies for AA have been tested, responses with traditional therapies have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7d42692d242e874d45b01a26cbba15
https://doi.org/10.1177/1203475418824079
https://doi.org/10.1177/1203475418824079
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 4:7-10
Background: Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disease characterized by sterile pustules, erythema, and scaling on the palms or soles of the feet. Apremilast is a systemic agent that inhibits phosphodiesterase 4 and is appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec2d7c26efa2cebe07844196bf2bdddb
https://doi.org/10.1177/2475530318806255
https://doi.org/10.1177/2475530318806255